10:49 AM EDT, 03/25/2024 (MT Newswires) -- Emergent Biosolutions ( EBS ) said Monday that the US Food and Drug Administration gave its Baltimore Bayview manufacturing facility a "No Action Indicated" status classification.

The company said the status means the facility complies with current good manufacturing practices.

Shares of Emergent Biosolutions ( EBS ) were up more than 6% in recent trading.

Price: 2.57, Change: +0.16, Percent Change: +6.60